Literature DB >> 9709746

Idiopathic polypoidal choroidal vasculopathy of the macula.

R S Moorthy1, A T Lyon, M F Rabb, R F Spaide, L A Yannuzzi, L M Jampol.   

Abstract

OBJECTIVE: The authors evaluated the clinical, fluorescein, and indocyanine green (ICG) angiographic characteristics of the macular variant of idiopathic polypoidal choroidal vasculopathy (IPCV).
DESIGN: Observational case series. PARTICIPANTS: The records, photographs, and fluorescein and ICG angiograms of eight eyes of seven patients with IPCV lesions confined to the macula were reviewed. MAIN OUTCOME MEASURES: The visual acuity, fundus examination, fluorescein and ICG angiographic characteristics, and clinical course were compared.
RESULTS: All patients demonstrated polypoidal lesions arising from macular choroidal vessels on ICG angiography. One patient had bilateral lesions. These lesions appeared hyperfluorescent in the early phases of both fluorescein and ICG angiography. Late-phase leakage was seen in cases associated with subretinal fluid or exudate. None of these patients demonstrated polypoidal lesions arising from the peripapillary choroidal circulation or peripapillary choroidal neovascularization. Three eyes with polypoidal lesions that were associated with subretinal fluid and exudates were treated with photocoagulation. Five eyes were not treated. Final visual acuity ranged from 20/20 to hand motions. Severe visual loss was associated with vitreous and subretinal hemorrhage, but this resolved without permanent severe visual loss in several cases.
CONCLUSIONS: In the macular variant of IPCV, ICG and fluorescein angiography demonstrate characteristic macular polypoidal lesions without evidence of peripapillary lesions. The vascular origin of these polypoidal lesions appears to be the macular choroidal circulation. This is distinguished from classic IPCV, in which lesions appear to arise from the peripapillary choroidal circulation. Visual prognosis appears to be good, with most patients retaining visual acuity of 20/80 or better. If subretinal fluid or exudates reduce visual acuity, photocoagulation should be considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9709746     DOI: 10.1016/S0161-6420(98)98016-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  37 in total

1.  The origins of polypoidal choroidal vasculopathy.

Authors:  M Yuzawa; R Mori; A Kawamura
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

2.  Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography.

Authors:  Fumi Gomi; Miki Sawa; Keiichi Mitarai; Motokazu Tsujikawa; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-09       Impact factor: 3.117

3.  Polypoidal choroidal vasculopathy with an appearance similar to classic choroidal neovascularisation on fluorescein angiography.

Authors:  Tomohiro Iida
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

4.  Functional changes following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Chengguo Zuo; Feng Wen; Jiaqing Li; Yan Liu; Shixian Long; Shizhou Huang; Meng Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-10-15       Impact factor: 3.117

5.  Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Hideki Koizumi; Tetsuya Yamagishi; Taizo Yamazaki; Ryo Kawasaki; Shigeru Kinoshita
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-28       Impact factor: 3.117

6.  Development of polypoidal lesions in age-related macular degeneration.

Authors:  A Tsujikawa; Y Ojima; K Yamashiro; S Ooto; H Tamura; I Nakata; N Yoshimura
Journal:  Eye (Lond)       Date:  2011-01-21       Impact factor: 3.775

7.  Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study.

Authors:  A Okubo; M Sameshima; A Uemura; S Kanda; N Ohba
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

8.  Polypoidal choroidal vasculopathy in elderly Chinese patients.

Authors:  Feng Wen; Changzheng Chen; Dezheng Wu; Haitao Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-29       Impact factor: 3.117

9.  Prospective evaluation of subretinal vessel location in polypoidal choroidal vasculopathy (PCV) and response of hemorrhagic and exudative PCV to high-dose antiangiogenic therapy (an American Ophthalmological Society thesis).

Authors:  Gregg T Kokame
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

10.  Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage.

Authors:  Jin Sook Yoon; Jonghyun Lee; Sung Chul Lee; Hyoung Jun Koh; Sung Soo Kim; Oh Woong Kwon
Journal:  Yonsei Med J       Date:  2007-04-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.